Pure Global

Medication transfer set

Access comprehensive regulatory information for Medication transfer set in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Sanofi-Aventis Australia Pty Ltd, manufactured by Sanofi Pasteur in France. The device registration started on February 23, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Medication transfer set
Australia TGA ARTG Registered Device
Good Name: Sanofi-Aventis Australia Pty Ltd - Medication transfer set
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Merieux inactivated rabies vaccine (AUST R 26675) is a vaccine indicated for : Post exposure immunisation against rabies and Pre-exposure immunisation in persons at special risk of contracting rabies. Each pack contains one dose of freeze-dried vaccine in a vial and one dose of 0.4% sodium chloride diluent in a one 1.0 mL syringe and two needles (16mm and 25mm) for reconstitution and administration.

Device Classification
Risk Class
Class IIa
Product Type
Procedure Pack
ARTG Category
General
Registration Information
Start Date
February 23, 2021
Effective Date
February 23, 2021
Manufacturer
Country
France
Address
1541 Avenue Marcel Merieux, 69280 Marcy L'Etoile